{
    "clinical_study": {
        "@rank": "30125", 
        "arm_group": [
            {
                "arm_group_label": "Methylphenidate", 
                "arm_group_type": "Experimental", 
                "description": "The study medication will consist of identical capsules filled Concerta\u00ae over-encapsulated to preserve double-blinding. The weekly dosages will be low, medium, and high based on weight cut-offs. Participants weighing less than 25kg will receive 18mg (low), 27mg (medium), and 36mg (high) dosages and participants weighing above 25kg will receive 18mg (low), 36mg (medium), and 54mg (high) dosages during the 3-week upward titration trial. Weekly ratings monitoring behavioral and side effect symptoms score and the Pittsburgh Side Effects Rating Scale."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "The study medication will consist of identical capsules filled with an inert white power (placebo). Weekly ratings monitoring behavioral and side effect symptoms score and the Pittsburgh Side Effects Rating Scale."
            }
        ], 
        "brief_summary": {
            "textblock": "The objectives of the study are to (1) determine the efficacy and dose-response of\n      methylphenidate treatment of attention problems after pediatric traumatic brain injury (TBI)\n      and (2) provide a better understanding of the relationship of a prior history of attention\n      deficit hyperactivity disorder (ADHD), ADHD subtypes after TBI, executive function, and\n      attentional control to treatment efficacy. The proposed clinical trial will enroll 50\n      children, age 6-17 years, with attention problems 12-48 months after moderate to severe TBI\n      into a randomized, double-blind, placebo-controlled, cross-over design trial with 3 dose\n      conditions (low, medium, and high)."
        }, 
        "brief_title": "Methylphenidate for Attention Problems After Pediatric TBI", 
        "completion_date": {
            "#text": "August 2018", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Traumatic Brain Injury", 
            "TBI", 
            "ADHD"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Brain Injuries", 
                "Wounds and Injuries"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Between ages of 6-17\n\n          -  Sustained Moderate to Severe TBI\n\n          -  TBI occurred 12 to 48 months prior to beginning the study\n\n          -  TBI occurred no earlier than 5 years of age\n\n          -  Positive endorsement of 6 out of 9 items on the Vanderbilt ADHD inattention or\n             hyperactivity scale\n\n          -  Enrolled in a school setting rather than a home-school program\n\n        Exclusion Criteria:\n\n          -  History of developmental disability or mental retardation\n\n          -  Current active participation in ADHD-related behavioral intervention\n\n          -  History of psychiatric condition requiring an inpatient admission in past 12 months\n\n          -  Actively taking 2 or more medications for treatment of a diagnosed psychiatric\n             condition\n\n          -  Current use of stimulant medication or ADHD specific medications that cannot be\n             discontinued\n\n          -  Non-blunt head injury\n\n          -  Family history of arrhythmia\n\n          -  Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "17 Years", 
            "minimum_age": "6 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01933217", 
            "org_study_id": "1K23HD074683-01A1"
        }, 
        "intervention": [
            {
                "arm_group_label": "Methylphenidate", 
                "intervention_name": "Methylphenidate", 
                "intervention_type": "Drug", 
                "other_name": "Concerta"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Methylphenidate"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "TBI", 
            "traumatic brain injury", 
            "ADHD", 
            "methylphenidate", 
            "Concerta", 
            "attention problems"
        ], 
        "lastchanged_date": "March 5, 2014", 
        "location": {
            "contact": {
                "email": "jessica.king1@cchmc.org", 
                "last_name": "Jessica King, BA", 
                "phone": "513-636-9631"
            }, 
            "facility": {
                "address": {
                    "city": "Cincinnati", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "45229"
                }, 
                "name": "Cincinnati Children's Hospital Medical Center"
            }, 
            "investigator": {
                "last_name": "Brad Kurowski, MD, MS", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Efficacy of Methylphenidate for Management of Long-Term Attention Problems After Pediatric Traumatic Brain Injury (TBI)", 
        "overall_official": {
            "affiliation": "Children's Hospital Medical Center, Cincinnati", 
            "last_name": "Brad Kurowski, MS, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Cincinnati Children's Hospital Medical Center: USA", 
                "National Institute of Health: USA"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Parent report measures", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01933217"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Neuropsychological Testing", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }, 
            {
                "measure": "Teacher Report Measures", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }
        ], 
        "source": "Children's Hospital Medical Center, Cincinnati", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Children's Hospital Medical Center, Cincinnati", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}